Erik Lamberth

Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults

Allison Thompson, Erik Lamberth, Joseph M. Severs et al. · Vaccine · 2019 · 100 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United States

Shelly Senders, Nicola P. Klein, Erik Lamberth et al. · The Pediatric Infectious Disease Journal · 2021 · 61 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

CLOVER (CLOstridium difficile Vaccine Efficacy tRial) Study: A Phase 3, Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of <i>Clostridioides difficile</i> Infection

Curtis J. Donskey, Erik R. Dubberke, Nicola P. Klein et al. · Clinical Infectious Diseases · 2024 · 32 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +17

A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile vaccine in healthy adults 65 to 85 years of age

Shane Christensen, Salim Bouguermouh, Kumar Ilangovan et al. · Vaccine · 2023 · 16 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17